Germline mutations affecting the RB1 gene are strongly associated with retinoblastoma development in children, and recent evidence has revealed an increased risk of different malignancies, including breast cancers, among patients cured from hereditary retinoblastoma [2]. This evidence concerns the gene RB1 and breast cancer.